Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Localised Prostate Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02618161
What this trial is testing

Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life Assessment

Who this might be right for
Prostate Cancer
Mid and South Essex NHS Foundation Trust 100
Large-scale testing (Phase 3)Looking for participantsNCT03258320
What this trial is testing

A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients

Who this might be right for
Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine 300
Not applicableLooking for participantsNCT07115992
What this trial is testing

Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogram≥7%

Who this might be right for
Prostate CancerProstate Adenoma
Ruijin Hospital 270
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT02923180
What this trial is testing

Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33
Large-scale testing (Phase 3)Study completedNCT00288080
What this trial is testing

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 612
Testing effectiveness (Phase 2)Study completedNCT00487721
What this trial is testing

The Effect of High-dose Silybin-phytosome in Men With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Colorado, Denver 12
Not applicableStudy completedNCT05303558
What this trial is testing

High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy

Who this might be right for
High Risk Localized Prostate Cancer
Johnson & Johnson International (Singapore) Pte. Ltd. 221
Testing effectiveness (Phase 2)Study completedNCT02628041
What this trial is testing

HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 30
Very early researchStudy completedNCT04301414
What this trial is testing

Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Columbia University 26
Not applicableWithdrawnNCT00537849
What this trial is testing

Investigational Study For the Treatment of Localized (T1c/T2a) Prostate Cancer With High Intensity Focused Ultrasound (HIFU) Using the Sonablate 500 (SB-500) System in Canada

Who this might be right for
Prostate Cancer
SonaCare Medical
Not applicableLooking for participantsNCT07757490
What this trial is testing

Sonablate HIFU International Registry for PC & BPH Patients

Who this might be right for
Localized Prostate CancerBPH (Benign Prostatic Hyperplasia)Prostate Cancer; Benign Prostatic Hyperplasia
Sonablate 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT04947254
What this trial is testing

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

Who this might be right for
Prostate CarcinomaStage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+4 more
M.D. Anderson Cancer Center 200
Testing effectiveness (Phase 2)Study completedNCT00924469
What this trial is testing

Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT04253483
What this trial is testing

Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer

Who this might be right for
Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8+2 more
Rutgers, The State University of New Jersey 14
Testing effectiveness (Phase 2)Ended earlyNCT00321698
What this trial is testing

Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 25
Not applicableStudy completedNCT04602208
What this trial is testing

FOCAL HIGH-INTENSITY FOCUSED ULTRASOUND FOR PRIMARY LOCALIZED PROSTATE CANCER: MIDTERM ONCOLOGICAL OUTCOMES

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 146
Testing effectiveness (Phase 2)Looking for participantsNCT05593497
What this trial is testing

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

Who this might be right for
High-Risk Prostate Cancer
VA Office of Research and Development 30
Early research (Phase 1)Active Not RecruitingNCT04486755
What this trial is testing

Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Maryland, Baltimore 18
Not applicableLooking for participantsNCT06200974
What this trial is testing

Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer

Who this might be right for
Localized Prostate Carcinoma
British Columbia Cancer Agency 100
Next Page